Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Intima Bioscience

Main focus: Next generation cell therapies for solid tumours

Company stage: Clinical

Diseases: Multiple solid tumours

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: New York, USA


Intima Bioscience is a clinical-stage gene and cell therapy company focused on developing cures for solid cancers. The company develops tumour-infiltrating lymphocytes (TILs) in which the novel cytokine checkpoint CISH is disrupted using CRISPR. The company is currently testing its lead programme in multiple solid tumours in a Phase 1/2 clinical trial.


HashtagIntima Bioscience, Inc.

Company: Intima Bioscience
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine